204 related articles for article (PubMed ID: 33416261)
1. Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer.
Mendonça Gorgulho C; Krishnamurthy A; Lanzi A; Galon J; Housseau F; Kaneno R; Lotze MT
J Immunother; 2021 Feb-Mar 01; 44(2):49-62. PubMed ID: 33416261
[TBL] [Abstract][Full Text] [Related]
2. T-cell-based immunotherapy in colorectal cancer.
Feng M; Zhao Z; Yang M; Ji J; Zhu D
Cancer Lett; 2021 Feb; 498():201-209. PubMed ID: 33129958
[TBL] [Abstract][Full Text] [Related]
3. Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective.
Liu N; Shan F; Ma M
Int Immunopharmacol; 2021 Oct; 99():108017. PubMed ID: 34352568
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer Immunotherapy: Options and Strategies.
Johdi NA; Sukor NF
Front Immunol; 2020; 11():1624. PubMed ID: 33042104
[TBL] [Abstract][Full Text] [Related]
6. Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.
Quiroga D; Lyerly HK; Morse MA
Curr Treat Options Oncol; 2016 Aug; 17(8):41. PubMed ID: 27315067
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
Bai Z; Zhou Y; Ye Z; Xiong J; Lan H; Wang F
Front Immunol; 2021; 12():808964. PubMed ID: 35095898
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
Kim J; Lee HK
Front Immunol; 2021; 12():807648. PubMed ID: 35069592
[TBL] [Abstract][Full Text] [Related]
9. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
Picard E; Verschoor CP; Ma GW; Pawelec G
Front Immunol; 2020; 11():369. PubMed ID: 32210966
[TBL] [Abstract][Full Text] [Related]
10. An update on the use of immunotherapy in patients with colorectal cancer.
Nguyen M; Tipping Smith S; Lam M; Liow E; Davies A; Prenen H; Segelov E
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):291-304. PubMed ID: 33138649
[No Abstract] [Full Text] [Related]
11. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
12. Current Microsatellite Instability Testing in Management of Colorectal Cancer.
Sun BL
Clin Colorectal Cancer; 2021 Mar; 20(1):e12-e20. PubMed ID: 32888812
[TBL] [Abstract][Full Text] [Related]
13. Current advancements and future perspectives of immunotherapy in colorectal cancer research.
Kishore C; Bhadra P
Eur J Pharmacol; 2021 Feb; 893():173819. PubMed ID: 33347822
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Pelster MS; Amaria RN
Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
[TBL] [Abstract][Full Text] [Related]
15. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors.
Tong H; Wei H; Smith AO; Huang J
Front Immunol; 2021; 12():802049. PubMed ID: 35069586
[TBL] [Abstract][Full Text] [Related]
16. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
Lin PS; Semrad TJ
Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in colorectal cancer: current achievements and future perspective.
Fan A; Wang B; Wang X; Nie Y; Fan D; Zhao X; Lu Y
Int J Biol Sci; 2021; 17(14):3837-3849. PubMed ID: 34671202
[TBL] [Abstract][Full Text] [Related]
18. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy.
Montalban-Arques A; Scharl M
EBioMedicine; 2019 Oct; 48():648-655. PubMed ID: 31631043
[TBL] [Abstract][Full Text] [Related]
20. Developments in immunotherapy for gastrointestinal cancer.
Diaz JL; Wanta SM; Fishbein TM; Kroemer A
Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
